Av
När investeringsbolaget Karolinska Development i november 2011 släppte sin förlustrapport för perioden juli-september meddelade de att de lade ner portföljbolaget Avaris. Detta för att Avaris inte uppnått uppsatta mål och att Karolinska Development som enda finansiär skulle strypa finansieringen. Under 2011 har ytterligare två portföljbolag lagts ned, Imed och Eribis, och bolaget fortsätter att leverera röda siffror.
Karolinska Development redovisar en förlust på -385,7 miljoner kronor för helåret 2011. Detta kan jämföras med resultatet för 2010 som var -334,6 miljoner kronor. Tappet blev dock inte lika stort under det fjärde kvartalet 2011 som under samma period året dessförinnan. Under perioden oktober-december 2011 blev resultat efter skatt -114,4 miljoner kronor, vilket är en mindre förlust än samma period året innan som var -219 miljoner kronor.
Även intäkterna visar dystra siffror jämfört med fjolårets rapport. För helåret 2011 uppgår intäkterna till 10,5 miljoner kronor, vilket kan jämföras med intäkterna för 2010 som var 13,9 miljoner kronor.
Karolinska Development gick in på börsen under året och gjorde i samband med noteringen en nyemission som gav bolaget 608 miljoner kronor. Vid slutet av 2011 hade Karolinska Development en kassa på 620 miljoner kronor.
Karolinska Development redovisar en förlust på -385,7 miljoner kronor för helåret 2011. Detta kan jämföras med resultatet för 2010 som var -334,6 miljoner kronor. Tappet blev dock inte lika stort under det fjärde kvartalet 2011 som under samma period året dessförinnan. Under perioden oktober-december 2011 blev resultat efter skatt -114,4 miljoner kronor, vilket är en mindre förlust än samma period året innan som var -219 miljoner kronor.
Även intäkterna visar dystra siffror jämfört med fjolårets rapport. För helåret 2011 uppgår intäkterna till 10,5 miljoner kronor, vilket kan jämföras med intäkterna för 2010 som var 13,9 miljoner kronor.
Karolinska Development gick in på börsen under året och gjorde i samband med noteringen en nyemission som gav bolaget 608 miljoner kronor. Vid slutet av 2011 hade Karolinska Development en kassa på 620 miljoner kronor.
"We are entirely devoted to luminescence technology." 
"To be the most attractive node and business platform in the Nordic countries for new and innovative Life Science companies" 
"As a full service CRO with offices in all Nordic countries we can provide our customer with professional support throughout the clinical research." 
"Your global partner of pharmaceutical service and cGMP manufacturing" 
"With our first class products and our committed and skilled colleagues we guarantee our customers the best support in the market, at no extra charge." 
"Together with Zacco our clients achieve their business goals through the management of their intellectual property." 
"Uppsala BIO is a life science pathfinder. We build ways to make life science flourish, in cooperation with industry, academia, society and healthcare." 
"Allenex is a life science company that develops, manufactures, markets and sells high quality products for the transplantation market." 
"To be acknowledged as the Best-in-Class provider of pharmaceutical development and manufacturing services by customers, employees & other stakeholders" 
"Medivir is a specialty pharmaceutical company with unique positioning on the Nordic market and our goal is become a profitable company in high growth" 
"VWR is a global laboratory distributor of chemicals, life science products, consumables, equipment, instruments, furniture, e-commerce and services" 
"Dilafor is developing new products in the field of obstetrics, to provide an effective solution to the challenge of dystocia or protracted labor"
" 
"Our organisation value is to contribute to positioning Scandinavian healthcare and research in absolute world class." 
"Best in class companies see the value of optimising their business by having an effective strategy for information management and documentation." 
"Discover your possibilities in one of Europe´s most productive life science regions. Welcome to Stockholm-Uppsala."
" 
"We offer effective staffing solutions provided by specialists, we understand a company’s specific needs and we know where to find the best talent." 
"We aim to be the pioneering benchmark in user-friendly software experience in combination with the highest level of quality." 
"Our services in ligand-based and structure-based drug design is a cost-efficient alternative for smaller pharmaceutical companies" 
"Anton Paar is a product and service leader in the field of scientific instruments. We deliver uncompromised quality in everything we do." 
"We are making it more attractive for companies to invest in innovation with reduced corporation tax on profits from patents to 10%." 
"PCG - a professional full service CRO for your clinical trials.
Powered by Viedoc, globally trusted eCRF, keeping trials within budget and timelines" 
"Mercodia has been a supplier of reliable assays since 1991" 
"To become an internationally leading dental company with innovative, proprietary products of high therapeutic and commercial value." 
"We promise to go the extra mile every day to ensure you receive the highest level of service and value with each shipment you entrust to us." 
"APL provides high-quality services to Life Science. We are a Dedicated Partner from Discovery to Market." 
"Our vision is to become one of the top 10 global providers of scientific instruments; we will get there by striving for market leadership in our respective product and application niches."
" 
"Novel products for CVD treatment and prevention." 
"We turn medical research into applications for better health and well-being." 
"Our aim is to be the best drug development partner to the biotechnology and pharmaceutical industry no matter where you are based." 
"We have a unique technological platform, built around 5HT-receptor antagonism, for the treatment of inflammation and pain"." 
"To supply Swedish and Danish laboratories with laboratory equipment and furniture of highest quality and offer service on all delivered products." 
"Our reliability, customer service, global network and integrated technology make World Courier service truly "A service no one else can deliver"." 
"Your work is important to us, we are committed to your success.
Innovative tools? Please download the Promega app." 
"We are recognized as a flexible partner with short decision and lead times plus a proven record for the highest quality and cost efficiency." 
"Our products enable an increased number of transplants leading to substantial cost savings for society and increased quality of life for patients." 
"To adapt Competent Authorities´ requirements into opportunities is not just an artform - today it´s a business necessity." 
"To develop innovative and effective pharmaceuticals within autoimmune/ inflammatory diseases and cancer where major medical need exists" 
"TFS is today the leading European development partner for biopharmaceutical companies in their global clinical development process." 
"Our goal is to invest in innovations and develop new unique pharmaceuticals" 
"We help our clients create significant business value through scientific expertise." 
"The PolyPeptide Group is a world class manufacturer of peptide active pharmaceutical ingredients." 
"Innovation takes place when biology meets engineering; ICT is an enabler to solve the needs for increased functionality and reduced cost in Life Science" 
